medical management of colorectal cancer dr. patricia tang md frpcp southern alberta gi tumor group...
TRANSCRIPT
Medical Management of Medical Management of Colorectal CancerColorectal Cancer
Dr. Patricia Tang MD FRPCPSouthern Alberta GI Tumor Group Leader
Medical OncologistTom Baker Cancer Centre
Faculty/Presenter Disclosure
Dr. Patricia Tang
Relationships with commercial interests:
Speakers Bureau/Honoraria: Roche, Sanofi, Amgen, Celgene
Colorectal CancerColorectal Cancer
Epidemiology
• 4th most commonly diagnosed cancer in Canadians (22,000 new cases per year)
• 2nd leading cause of cancer death after lung cancer
• lifetime risk of developing CRC is 1 in 18
What are risk factors for developing colorectal cancer?
Risk Factors for Colorectal Cancer (CRC)
• age (>50)• lifestyle: diet (high calorie and fat, low fibre),
smoking, alcohol, obesity• genetics (family Hx of CRC, FAP, HNPCC, MUTYH
associated polyposis)• personal Hx of CRC or adenomas (esp. villous)• ulcerative colitis, Crohn’s disease• Prior abdominal or pelvic radiation
Patient Case 1Patient Case 1
Presentation
• 68 year old man presents to his family doctor with fatigue:– hemoglobin 100 (Normal Range = 137-180)– MCV 75 (Normal Range = 82-100)
• Past Medical History– Diabetes Mellitus Type 2 on metformin– Hypertension on ramipril– Dyslipidemia on atorvastatin– ASA 81 mg / day
• Next steps?
Diagnosis
• Physical examination is performed• Digital rectal exam reveals a palpable mass in
the rectum
Copyright unknown
Work up
• Baseline laboratory work: CBC CR LYTES LFTS CEA, (INR if on warfarin)
• Refer for urgent endoscopy: in Calgary, page the gastroenterologist on call at the nearest hospital (ROCA)
Diagnosis
• A gastroenterologist performs an urgent colonoscopy
http://www.cancercare.ns.ca/en/home/preventionscreening/coloncancerprevention/faq.aspx
• A biopsy of the mass was taken and sent to a pathologist who confirms moderately differentiated adenocarcinoma (up to 1 week)
Diagnosis: Rectal Cancer
http://www.proteinatlas.org/dictionary/cancer/colorectal+cancer/detail+1
• Gastroenterologist receives the pathology report and orders a CT scan of the chest, abdomen and pelvis
• CT scan: Rectal mass, otherwise, completely normal
Staging
http://www.radiologyinfo.org/en/photocat/gallery3.cfm?image=abdo-ct-ped.jpg&pg=abdominct
Which has the highest risk of local recurrence?
Colon Cancer Rectal Cancer
Copyright unknown
Staging
• If emergent surgery is not needed, the surgeon would order a MRI pelvis
Copyright unknown
Preoperative “Neoadjuvant” Treatment
• Locally advanced rectal adenocarcinomas (T3/4 or node positive on MRI) would be referred to the cancer centre for neoadjuvant chemoradiation– Goal: reduce local recurrence & shrink the tumor
• Then surgery to cut out the cancer• Then further adjuvant chemotherapy
Copyright unknown
• Referred to the cancer centre to see a radiation oncologist and medical oncologist
• Capecitabine (pills) given concurrently with radiation for 5 weeks
• The patient has mild diarrhea and hand-foot syndrome
• 6-8 week wait prior to OR
Treatment: Chemoradiotherapy
Copyright unknown
• Surgery: low anterior resection with diverting loop ileostomy
• Loose ileostomy output: metamucil, imodium, codeine
Treatment: Surgery
Copyright unknownIleostomy sometimes
Lower tumors, Abdominoperineal resection: Permanent colostomy
An ostomy is life changing
• Pathologist evaluates the specimen, the tumor is staged at T3N1 (3 out of 20 lymph nodes)M0 Stage III
• Referred back to the cancer centre for adjuvant chemotherapy and the patient receives 4 months of capecitabine
Physical &CT scan
Pathologic Staging
Stage I-IIICurative Intent
How you can help while the patient is on treatment
• Past Medical History– Diabetes Mellitus Type 2 on metformin: if a patient receives IV chemo,
we often worsen diabetic control• Backup plan for hyperglycemia • Chemo can cause nausea/vomiting: back up plan for poor oral intake
– Hypertension on ramipril• Some patients lose weight, which treats their hypertension• May need adjustments
– Dyslipidemia on atorvastatin: ongoing prescriptions for continuitiy– ASA 81 mg / day: This is fine. However, A fib requiring
anticoagulation often requires LMWH, Novel anticoagulants controversial
• Loop ileostomy is reversed. Bowel function takes awhile to improve
• Surveillance:– CEA (blood test) q 3 mo x 3 yrs then q6 months x 2 yrs– physical exam q6 mo x 3 yrs then annually– CT Chest abdomen pelvis annually x 3 years– colonoscopy within 6-12 mos of surgery then q3-5 years
• What are common places of metastases?
Surveillance: Family Medicine
Surveillance: Family Medicine
• Intensive surveillance in colorectal cancer has been shown to improve survival since isolated liver and/or lung metastases can be resected and patients can still be cured
• 5 year Overall Survival 40%
Approach to a Rising CEA• Repeat CEA, if still > 5, physical exam• CT chest abdomen pelvis
– If resectable metastasis, send to appropriate surgeon (Thoracics or Hepatobiliary)
• If normal, colonoscopy• Send back to medical oncology/Call the original
medical oncologist– fax 403-521-3245, May need a biopsy
• Thoracic Oncology Program for lung/mediastinal LN
• Small pulmonary nodule seen in right lung on the CT scan suggestive of recurrent cancer (metastasis)
Thoracic surgeonResects the cancer
Metastatic Colorectal Cancer
Copyright unknown
• Pathology from the lung surgery revealed a 1 cm focus of metastatic rectal adenocarcinoma
• Started on “adjuvant” FOLFOX chemotherapy for 6 months
• At 5 years the CT scan was clear and the patient’s intensive surveillance was discontinued
Treatment of Resectable Metastatic CRC
What are the current colorectal cancer screening guidelines?
Screening for CRC
• beginning at age 50, all patients should have one of the following screening tests for CRC:– FOBT q1year– flexible sigmoidoscopy q5years– double-contrast barium enema q5years– colonoscopy q10years
• any positive or abnormal test should be followed up with colonoscopy
http://www.topalbertadoctors.org/download/301/colorectal_summary.pdf?_20150805182214
http://www.screeningforlife.ca/
Screening for CRC
http://www.topalbertadoctors.org/download/301/colorectal_summary.pdf?_20150805182214
Lynch: Dr. W D Buie and Dr Bellutruti
Clinical Presentation of CRC
Copyright unknown
Clinical Presentation
• abdominal pain• bowel change (diarrhea, constipation, pencil stools,
tenesmus)• hematochezia• weight loss• fatigue• iron-deficiency anemia• bowel obstruction• elevated liver enzymes (liver mets)
Diagnostic Approach
• CBC, lytes, BUN, Cr, liver enzymes & LFTs, CEA
• CT chest/abdomen/pelvis
• colonoscopy (tissue diagnosis)
• liver lesions: may need extra imaging such as ultrasound and/or MRI
• rectal lesions: endoscopic ultrasound and/or MRI
Colon Cancer Treatment
Stage Treatment 5 year Overall Survival
I: T1-2 N0 Surgery 93%
II: T3 N0 T4 N0
SurgeryAdjuvant chemotherapy for high risk
72%85%
IIIA: T1-2N0IIIB: T3-4N1IIIC: T1-4N2
SurgeryAdjuvant chemotherapy for high risk
72%64%44%
IV: Distant Metastases Chemotherapy if well enough
Select patients may be eligible for Metastatectomy
10%
40%
Treatment after surgery for Stage III Colorectal Cancer
• FOLFOX is the standard of care for adjuvant treatment of stage III CRC and improves 5 year survival by 10% to 20% compared to no further chemotherapy– Can cause chronic peripheral neuropathy
• Painful neuropathy can be helped with Duloxetine
• capecitabine has been shown to be equivalent to 5-FU/LV and is routinely used for patients who cannot tolerate oxaliplatin (FOLFOX) or those who prefer oral chemotherapy
Patient Case 2
• 55 year old post-menopausal woman presents with fatigue, 20 lb un-intentional weight loss, and progressively narrow stool caliber
Approach
• History• Physical Exam• Labwork
Results
• Hb 75, MCV 72• ALT is 1.5 x upper limit of normal (it was
normal last year)
Results
• U/S Abdomen shows innumerable liver metastases
• Next step
Patient Case
• CT chest abd pelvis: innumerable liver and lung metastases
• Refer to GI for urgent scope– Non-obstructing mass in the sigmoid colon– Pathology: adenocarcinoma
• GP refers to cancer centre for further management
Stage IV CRC
ASCO Colorectal Slide Deck 2008
• cancer has spread outside of colon or rectum to other areas of body
• stage IV cancer is usually treated with chemotherapy alone
• surgery to remove the primary tumor may be done
• additional surgery to remove metastases may also be done in carefully selected patients
Treatment of Metastatic CRC
• Best Supportive Care 6• 5-fluorouracil (60’s) + leucovorin (80’s) 8 - 12• IFL (irinotecan/5-FU/LV) (2000) 15• FOLFIRI (irinotecan/5-FU/LV) (2000) 17• FOLFOX (oxaliplatin/5-FU/LV) (2000) 20• FOLFIRI FOLFOX (2004) 21• IFL + bevacizumab (2007) 20• FOLFIRI + cetuximab (2009) 24• FOLFIRI or FOLFOX + bevacizumab 29
or cetuximab (2014)
Median Survival (Months)
• Benefits: can shrink the cancer, delay time to progression and improve survival time
• Potential Toxicities: – myelosuppression febrile neutropenia– rash, photosensitivity– diarrhea– fatigue– coronary vasospasm/chest pain (rare)– * low rates of nausea and vomiting– * rare hair loss
Chemotherapy: 5-fluorouracil
• Benefits: can shrink the cancer, delay time to progression and improve survival time
• Potential Toxicities: – Myelosuppression febrile neutropenia– cold-induced dysesthesia– peripheral neuropathy– infusion reaction– * moderate rates of nausea and vomiting– * can have hair thinning
Chemotherapy: Oxaliplatin
Metastatic CRC May Be Curable• selected patients with oligometastatic disease isolated
to liver and/or lung
• refer to hepatobiliary surgeon or thoracic surgeon for opinion regarding metastectomy
• refer to medical oncologist for perioperative chemotherapy
• in case series where patients had liver metastasis resection:– 5Y-OS = 40%, 10Y-OS = 20%
Scenario 1
• You are a family doctor• You order a FIT test on your 51 year old
female patient as part of routine screening• It comes back POSITIVE• Next step:
a. Refer to the cancer centreb. Refer to surgeonc. Refer for colonoscopy
Scenario 2
• You are an Emergency Room doctor• A patient presents with a bowel obstruction, CT
shows a mass suggestive of cancer in the colon that is obstructing, one mass in the liver suggestive of a metastasis
• Next step:a. Refer to the cancer centre because the CT is suggestive
of cancerb. Refer to surgery because the patient is obstructed
Proposed Rectal Cancer PathwayRectal Cancer Clinical Pathway – Standards of Care
No neoadjuvant therapy for colon
In Summary
• colorectal cancer (CRC) is a common disease
• screen for CRC in general population age ≥50
• surgical resection for cure in stage I-III CRC
• adjuvant chemotherapy (5-FU, capecitabine, FOLFOX) increases overall survival in stage III CRC and possibly in high-risk stage II
In Summary
• oligometastatic CRC isolated to the liver and/or lungs can be resected for chance at cure in selected patients
• modern chemotherapy and biologic therapy are effective and generally well-tolerated palliative treatments for metastatic CRC
• median survival for patients with metastatic CRC with treatment is now >2 years
Questions???• http://whatnow.atlargecommunications.com/• Above website will be eventually migrated to
Cancerwhatnow.com• http://www.colorectal-cancer.ca/en/ostomy/
•
http://www.albertahealthservices.ca/info/cancerguidelines.aspxhttp://www.bccancer.bc.ca/health-professionals/professional-
resources/cancer-management-guidelines